Evome Medical Technologies Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was CAD 15.6 million. Basic loss per share from continuing operations was CAD 0.21.

Diluted loss per share from continuing operations was CAD 0.21.